IFNWP19

Across TCGA pan-cancer cohorts, IFNWP19 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated IFNWP19 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher IFNWP19 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IFNWP19 expression acts as an unfavorable survival marker, although some lineages such as THCA and KIRP show a favorable association.

LUAD, UCEC, and HNSC are the cancer types where IFNWP19 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.549	0.780	<.001	120	view →
UCEC	DFS	Median	All	0.515	0.767	<.001	78	view →
HNSC	DFS	Median	All	0.658	0.759	.007	48	view →
UVM	OS	Tertile	All	0.698	0.915	<.001	43	view →
PAAD	DFS	Quartile	All	0.173	0.466	.002	37	view →
LIHC	OS	Tertile	All	0.466	0.722	.001	36	view →
KIRC	OS	Median	All	0.558	0.690	.001	33	view →
THCA	DFS	Quartile	All	0.940	0.554	.004	26	view →
READ	DFS	Quartile	IV	0.259	0.748	<.001	16	view →
KIRP	DFS	Quartile	All	0.966	0.834	.007	15	view →
COAD	DFS	Median	II,III,IV	0.587	0.723	.006	12	view →
CHOL	DFS	Median	IV	0.858	0.339	.017	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

IFNWP19–LUAD (OS)

Open the LUAD breakdown →